SavedAdd your journal

Journals / European Journal of Therapeutics / 2011 / Cilt: 17 Sayı: 2

Investigation of the association between ROCK1 gene Lys222Glu ve Arg1262Gln polymorphisms and breast cancer

ROCK1 geni Lys222Glu ve Arg1262Gln polimorfizmleri ile meme kanseri arasındaki ilişkinin araştırılması

Mehmet Emin KALENDER
Şeniz DEMİRYÜREK
Serdar ÖZTUZCU
Ayşe KIZILYER
Abdullah Tuncay DEMİRYÜREK
Ozan BALAKAN
Celaletdin CAMCI
Pages
77–81
Publication Date
2011-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this research, which is the first study to evaluate the role of ROCK1 gene polymorphisms in breast cancer, no associations between the Lys222Glu and Arg1262Gln polymorphisms and risk of developing breast cancer or metastasis have been found.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The purpose of this study was to evaluate the possible relationship between breast cancer metastasis and ROCK1 gene polymorphisms in Turkish population.
📊
Key Findings & Data:In this study, investigation of genotypic distribution and allele frequency of ROCK1 genes G15741A (Lys222Glu) and G156064A (Arg1262Gln) polymorphisms, and studying the association between these polymorphisms and tumor metastasis were aimed.
💡
Conclusion & Impact:In this research, which is the first study to evaluate the role of ROCK1 gene polymorphisms in breast cancer, no associations between the Lys222Glu and Arg1262Gln polymorphisms and risk of developing breast cancer or metastasis have been found.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Meme kanseri · polimorfizm · Rho-kinaz

Abstract

The purpose of this study was to evaluate the possible relationship between breast cancer metastasis and ROCK1 gene polymorphisms in Turkish population. In this study, investigation of genotypic distribution and allele frequency of ROCK1 genes G15741A (Lys222Glu) and G156064A (Arg1262Gln) polymorphisms, and studying the association between these polymorphisms and tumor metastasis were aimed. In the present study, we enrolled patients with breast cancer without metastasis at least 5 years (non-metastatic group, n=92), metastatic breast cancer patients (metastatic group, n= 101), and voluntary healthy women, with no disease and cancer history, no drug usage, no smoking and no alcohol abuse (control group, n=128). DNA was isolated from blood samples of patients and control group, and melting curve analyses were made with PCR method at LightCycler equipment. No significant differences in ROCK1 genes Lys222Glu and Arg1262Gln polymorphisms were observed between the control group and patients in terms of genotype and allele frequencies (P>0.05). In this research, which is the first study to evaluate the role of ROCK1 gene polymorphisms in breast cancer, no associations between the Lys222Glu and Arg1262Gln polymorphisms and risk of developing breast cancer or metastasis have been found.

Özet

Bu çalışmanın amacı, Türk popülasyonunda ROCK1 gen polimorfizmleri ile meme kanserinin metastaz yapma özelliği arasındaki muhtemel ilişkiyi araştırmaktır. Bu araştırmada, ROCK1 geninin G15741A (Lys222Glu) ve G156064A (Arg1262Gln) polimorfizmleri için genotip dağılımlarını ve allel frekansını araştırmak ve bu polimorfizmler ile tümör metastazı arasındaki ilişkiyi ortaya koymak amaçlanmıştır. Bu çalışmada, en az 5 yıl süreyle metastaz gelişmemiş meme kanseri olan hastalar (nonmetastatik grup, n=92), metastaz gelişmiş meme kanserli hastalar (metastatik grup, n=101) ve herhangi bir hastalığı olmayan, kanser geçmişi olmayan, ilaç kullanmayan, sigara içmeyen ve alkol kullanmayan sağlıklı bayan gönüllüler (kontrol grubu, n=128) çalışmaya alındı. Hastalardan ve kontrol grubundan alınan kan örneklerinden DNA izole edildi ve LightCycler cihazıyla PCR yöntemi kullanılarak erime eğrisi analizi yapıldı. ROCK1 geni Lys222Glu ve Arg1262Gln polimorfizmlerinin kontrol grubu ile hasta grupları arasında genotip ve allel frekansları bakımından anlamlı fark gözlenmemiştir (P>0.05). Meme kanserinde ROCK1 gen polimorfizmlerinin rolünü araştıran bu ilk çalışmada, Lys222Glu ve Arg1262Gln polimorfizmlerinin meme kanseri gelişme riski veya metastazı ile ilişkili olmadığı bulunmuştur.

🔖

Cite This Article

KALENDER, M. E., DEMİRYÜREK, Ş., ÖZTUZCU, S., KIZILYER, A., DEMİRYÜREK, A. T., BALAKAN, O., CAMCI, C. (2011). Investigation of the association between ROCK1 gene Lys222Glu ve Arg1262Gln polymorphisms and breast cancer. European Journal of Therapeutics, Cilt: 17 Sayı: 2, 77–81. https://ajindex.com/articles/977010

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010
  2. 60(5):277-300 2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007
  3. 18(3):581-92 3. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001
  4. 22(1):32-9 4. Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, et al. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho EMBO J 1996
  5. 15(9):2208-16 5. Tanaka T, Nishimura D, Wu RC, Amano M, Iso T, Kedes L, et al. Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase. J Biol Chem 2006
  6. 281(22):15320-9 6. Noma K, Oyama N, Liao JK. Physiological role of ROCKs in the cardiovascular system. Am J Physiol 2006
  7. 290(3):C661-8 7. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, et al. Regulation of myosin phosphatase by Rho and Rhoassociated kinase (Rho-kinase). Science 1996
  8. 273(5272):245-8 8. Fukata Y, Oshiro N, Kinoshita N, Kawano Y, Matsuoka Y, Bennett V, et al. Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. J Cell Biol 1999
  9. 145(2):347-61 9. Takamura M, Sakamoto M, Genda T, Ichida T, Asakura H, Hirohashi S. Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632. Hepatology 2001
  10. 33(3):577-81 10. Ying H, Biroc SL, Li WW, Alicke B, Xuan JA, Pagila R, et al Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models. Mol Cancer Ther 2006
  11. 5(9):2158-64 11. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999
  12. 5(2):221-5 12. Ruhi HI. Meme kanserinde farmakogenetik. Türkiye Klinikleri Tıp Bilimleri Derg 2010
  13. 30(Ek 1):16-21 13. Kalender ME, Demiryürek S, Oztuzcu S, Kizilyer A, Demiryürek AT, Sevinc A, et al. Association between the Thr431Asn polymorphism of the ROCK2 gene and risk of developing metastases of breast cancer. Oncol Res 2010
  14. 18(11-12):583-91 14. Burstein HJ, Haris JR, Morrow M. Malignant tumors of the Breast. In: DeVita VT, Lawrence TS, Rosenberg SA (eds) Cancer Principles and Practice of Oncology. (8th ed) Philadelphia, Lippincott Williams and Wilkins, 2008:1606-54 15. Yoshinaga K, Inoue H, Tanaka F, Mimori K, Utsunomiya T, Mori